ATE517631T1 - Prozess zur herstellung von ferutinin aus pflanzen der ferulafamilie - Google Patents

Prozess zur herstellung von ferutinin aus pflanzen der ferulafamilie

Info

Publication number
ATE517631T1
ATE517631T1 AT04722572T AT04722572T ATE517631T1 AT E517631 T1 ATE517631 T1 AT E517631T1 AT 04722572 T AT04722572 T AT 04722572T AT 04722572 T AT04722572 T AT 04722572T AT E517631 T1 ATE517631 T1 AT E517631T1
Authority
AT
Austria
Prior art keywords
ferutinin
ferul
plants
family
producing
Prior art date
Application number
AT04722572T
Other languages
English (en)
Inventor
Ezio Bombardelli
Gabriele Fontana
Aldo Cristoni
Enrico Mercalli
Original Assignee
Indena Spa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Indena Spa filed Critical Indena Spa
Application granted granted Critical
Publication of ATE517631T1 publication Critical patent/ATE517631T1/de

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C67/00Preparation of carboxylic acid esters
    • C07C67/08Preparation of carboxylic acid esters by reacting carboxylic acids or symmetrical anhydrides with the hydroxy or O-metal group of organic compounds
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/185Magnoliopsida (dicotyledons)
    • A61K36/23Apiaceae or Umbelliferae (Carrot family), e.g. dill, chervil, coriander or cumin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/33Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
    • A61K8/37Esters of carboxylic acids
    • A61K8/375Esters of carboxylic acids the alcohol moiety containing more than one hydroxy group
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/96Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
    • A61K8/97Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution from algae, fungi, lichens or plants; from derivatives thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/96Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
    • A61K8/97Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution from algae, fungi, lichens or plants; from derivatives thereof
    • A61K8/9783Angiosperms [Magnoliophyta]
    • A61K8/9789Magnoliopsida [dicotyledons]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00Drugs for dermatological disorders
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00Drugs for dermatological disorders
    • A61P17/08Antiseborrheics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00Drugs for dermatological disorders
    • A61P17/10Anti-acne agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00Drugs for dermatological disorders
    • A61P17/16Emollients or protectives, e.g. against radiation
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61QSPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00Preparations for care of the skin
    • A61Q19/08Anti-ageing preparations
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C67/00Preparation of carboxylic acid esters
    • C07C67/30Preparation of carboxylic acid esters by modifying the acid moiety of the ester, such modification not being an introduction of an ester group
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C67/00Preparation of carboxylic acid esters
    • C07C67/30Preparation of carboxylic acid esters by modifying the acid moiety of the ester, such modification not being an introduction of an ester group
    • C07C67/31Preparation of carboxylic acid esters by modifying the acid moiety of the ester, such modification not being an introduction of an ester group by introduction of functional groups containing oxygen only in singly bound form
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C69/00Esters of carboxylic acids; Esters of carbonic or haloformic acids
    • C07C69/76Esters of carboxylic acids having a carboxyl group bound to a carbon atom of a six-membered aromatic ring
    • C07C69/84Esters of carboxylic acids having a carboxyl group bound to a carbon atom of a six-membered aromatic ring of monocyclic hydroxy carboxylic acids, the hydroxy groups and the carboxyl groups of which are bound to carbon atoms of a six-membered aromatic ring
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C69/00Esters of carboxylic acids; Esters of carbonic or haloformic acids
    • C07C69/76Esters of carboxylic acids having a carboxyl group bound to a carbon atom of a six-membered aromatic ring
    • C07C69/84Esters of carboxylic acids having a carboxyl group bound to a carbon atom of a six-membered aromatic ring of monocyclic hydroxy carboxylic acids, the hydroxy groups and the carboxyl groups of which are bound to carbon atoms of a six-membered aromatic ring
    • C07C69/86Esters of carboxylic acids having a carboxyl group bound to a carbon atom of a six-membered aromatic ring of monocyclic hydroxy carboxylic acids, the hydroxy groups and the carboxyl groups of which are bound to carbon atoms of a six-membered aromatic ring with esterified hydroxyl groups
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C2602/00Systems containing two condensed rings
    • C07C2602/02Systems containing two condensed rings the rings having only two atoms in common
    • C07C2602/14All rings being cycloaliphatic
    • C07C2602/26All rings being cycloaliphatic the ring system containing ten carbon atoms
    • C07C2602/30Azulenes; Hydrogenated azulenes

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Dermatology (AREA)
  • Birds (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biotechnology (AREA)
  • Botany (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Gerontology & Geriatric Medicine (AREA)
  • Emergency Medicine (AREA)
  • Toxicology (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Medical Informatics (AREA)
  • Cosmetics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
AT04722572T 2003-04-04 2004-03-23 Prozess zur herstellung von ferutinin aus pflanzen der ferulafamilie ATE517631T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
IT000661A ITMI20030661A1 (it) 2003-04-04 2003-04-04 Processo per la preparazione della ferutinina da piante del genere ferula
PCT/EP2004/003055 WO2004087179A1 (en) 2003-04-04 2004-03-23 A process for the preparation of ferutinine from ferula genus plants

Publications (1)

Publication Number Publication Date
ATE517631T1 true ATE517631T1 (de) 2011-08-15

Family

ID=33105046

Family Applications (1)

Application Number Title Priority Date Filing Date
AT04722572T ATE517631T1 (de) 2003-04-04 2004-03-23 Prozess zur herstellung von ferutinin aus pflanzen der ferulafamilie

Country Status (20)

Country Link
US (4) US7371886B2 (de)
EP (1) EP1615651B1 (de)
JP (2) JP4648305B2 (de)
KR (2) KR101169893B1 (de)
CN (2) CN101371818A (de)
AT (1) ATE517631T1 (de)
AU (1) AU2004226853B2 (de)
BR (1) BRPI0409166B1 (de)
CA (2) CA2521100C (de)
DK (1) DK1615651T3 (de)
ES (1) ES2367361T3 (de)
HK (1) HK1087618A1 (de)
IL (1) IL171230A (de)
IT (1) ITMI20030661A1 (de)
NO (1) NO333671B1 (de)
PL (1) PL1615651T3 (de)
PT (1) PT1615651E (de)
RU (2) RU2342153C2 (de)
SI (1) SI1615651T1 (de)
WO (1) WO2004087179A1 (de)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ITMI20032286A1 (it) * 2003-11-24 2005-05-25 Indena Spa Composizioni per il trattamento di dermatiti atopiche di stati allergici cutanei e dell'acne
US8536584B2 (en) 2007-11-14 2013-09-17 Cree, Inc. High voltage wire bond free LEDS
US20100260695A1 (en) * 2009-04-09 2010-10-14 Mary Kay Inc. Combination of plant extracts to improve skin tone
WO2011147768A1 (en) * 2010-05-24 2011-12-01 Indena S.P.A. Tamarind seed polysaccharide for use in the treatment of inflammatory diseases
CA2834828A1 (en) 2011-05-12 2012-11-15 B.R.A.I.N. Biotechnology Research And Information Network Ag Small molecule inhibitors of trpa1
US9913799B2 (en) 2014-07-11 2018-03-13 Mary Kay Inc. Cosmetic compositions and methods of their use
CN105820146A (zh) * 2015-01-08 2016-08-03 辽宁医联新药研究所 一种阿魏内酯及其提取纯化的方法
GB2570508A (en) * 2018-01-30 2019-07-31 Saeed Mohammad Sultan Alaryani Humaid Preparation for treatment of wounds

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1604225A (en) 1978-05-15 1981-12-02 Skourides A A Extract of ambelferae for pharmacological use
JPH02500362A (ja) * 1987-05-29 1990-02-08 インスティテュト ヒミイ ラスティテルニハ ベスチェストフ アカデミイ ナウク ウズベクスコイ エスエスエル エストロゲン効果を有する製剤
RU2090198C1 (ru) * 1991-03-12 1997-09-20 Иван Иванович Уваров Способ получения биологически активных веществ, обладающих противогрибковой активностью
DE4444238A1 (de) * 1994-12-13 1996-06-20 Beiersdorf Ag Kosmetische oder dermatologische Wirkstoffkombinationen aus Zimtsäurederivaten und Flavonglycosiden
JP4244093B2 (ja) * 2000-01-24 2009-03-25 三省製薬株式会社 美白化粧料
US6737084B2 (en) * 2000-06-27 2004-05-18 Qualilife Compositions and methods for enhancing or treating female sexual response
US6623768B1 (en) * 2002-04-16 2003-09-23 Yousry M. A. Naguib Pharmaceutically active composition extracted from Ferula hermonis and process of its extraction

Also Published As

Publication number Publication date
WO2004087179A1 (en) 2004-10-14
US20120095094A1 (en) 2012-04-19
KR20060008307A (ko) 2006-01-26
HK1087618A1 (en) 2006-10-20
US20080248139A1 (en) 2008-10-09
JP4648305B2 (ja) 2011-03-09
JP5409505B2 (ja) 2014-02-05
BRPI0409166B1 (pt) 2015-09-01
CN101371818A (zh) 2009-02-25
KR101132526B1 (ko) 2012-04-03
KR101169893B1 (ko) 2012-07-31
IL171230A (en) 2014-02-27
US8247005B2 (en) 2012-08-21
US20060275246A1 (en) 2006-12-07
PL1615651T3 (pl) 2011-12-30
CA2521100A1 (en) 2004-10-14
NO333671B1 (no) 2013-08-05
NO20054545L (no) 2005-10-06
CN100518732C (zh) 2009-07-29
BRPI0409166A (pt) 2006-04-11
RU2469733C2 (ru) 2012-12-20
JP2006522043A (ja) 2006-09-28
RU2008122295A (ru) 2009-12-10
AU2004226853A1 (en) 2004-10-14
RU2005130639A (ru) 2006-04-27
US7371886B2 (en) 2008-05-13
ES2367361T3 (es) 2011-11-02
NO20054545D0 (no) 2005-10-03
KR20110082091A (ko) 2011-07-15
RU2342153C2 (ru) 2008-12-27
US8101215B2 (en) 2012-01-24
ITMI20030661A1 (it) 2004-10-05
DK1615651T3 (da) 2011-10-24
CA2766702C (en) 2015-09-29
PT1615651E (pt) 2011-09-02
JP2010209099A (ja) 2010-09-24
CA2521100C (en) 2012-05-01
CN1767841A (zh) 2006-05-03
US20100255125A1 (en) 2010-10-07
EP1615651A1 (de) 2006-01-18
SI1615651T1 (sl) 2011-11-30
CA2766702A1 (en) 2004-10-14
EP1615651B1 (de) 2011-07-27
AU2004226853B2 (en) 2009-06-04

Similar Documents

Publication Publication Date Title
DE602004020538D1 (de) Verfahren und Vorrichtung zur Laserbestrahlung, sowie Verfahren zur Herstellung von Halbleiter.
DE502005011078D1 (de) Herstellung von 3-pentennitril aus 1,3-butadien
DE60317586D1 (de) Verfahren zur Herstellung von mehrschichtigen, halbleitenden Nanopartikeln und und die nach diesem Verfahren erhaltenen mehrschichtigen, halbleitenden Nanopartikel
WO2004001019A3 (en) Novel nanoparticles and use thereof
ATE369315T1 (de) Flammenhydrolytisch hergestelltes siliciumdioxid, verfahren zu seiner herstellung und verwendung
DE60002286D1 (de) Verfahren zur Herstellung von Ketonen, Alkoholen und Hydroperoxiden
DE60318785D1 (de) Methode zur Herstellung von halbleitenden Nanopartikeln
DE60110044D1 (de) Teilentwässertes umsetzungsprodukt, verfahren zur herstellung desselben, und dasselbe enthaltende emulsion
NO20054545D0 (no) Fremgangsmate for fremstiilling av ferutinin fra Ferula genusplanter
DE60323994D1 (de) Verfahren zur herstellung von 2-chlor-1,1,1,2,3,3,3-heptafluorpropan, hexafluorpropen und 1,1,1,2,3,3,3-heptafluorpropan
DE60201498D1 (de) Verbesserter prozess zur herstellung von carbapenemen
EP1674474A4 (de) Cyclische maltosylmaltose, cyclischmaltosylmaltosesynthase, verfahren zu deren herstellung und deren verwendung
DE60316152D1 (de) Prozess zur herstellung von pioglitazon via verschiedene zwischenstufen
ATE372118T1 (de) Die verwendung von rosiglitazon zur behandlung von psychiatrischen erkrankungen.
DE60204464D1 (de) Verfahren zur herstellung von ethern, vorzugsweise von thf
DE60323456D1 (de) Herstellung von Nanopartikeln
DE50210322D1 (de) Verfahren zur herstellung von extrakten aus pelargonium sidoides und/oder pelargonium reniforme
DE60235820D1 (de) Verfahren zur herstellung von azoverbindungen
DE60138575D1 (de) Druckdecke und verfahren zur herstellung derselben
ATE460168T1 (de) Nicht-radioaktives strontiummittel zur behandlung von krebs
MXPA04004526A (es) N-metil-homocisteinas, su uso y metodo para su produccion.
DE10393714D2 (de) Pflanzenpigmente aus Leguminosen zur Revitalisierung menschlicher Haut
NO20064484L (no) Isopropanol-vannopplosning av olanzapin
DE60336275D1 (de) Verfahren zur Herstellung von 3-(1,3-Dihydroimidazol-2-thion-1-yl)-chromanen und thiochromanen als Dopamin-beta-hydroxylase Inhibitor
DE60127111D1 (de) Ethyl-4-(thioacetoxy)butyrat als aromastoff sowie verfahren zur herstellung und verwendung desselben

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 1615651

Country of ref document: EP